4 w. ago Corona Remedies IPO: What Does GMP Signal About Listing Pop?

The grey market premium for the Corona Remedies IPO suggests a 25%+ listing pop for investors.

Events

4 w. ago Corona Remedies IPO Allotment: Date, Steps To Check Status On BSE, NSE, MUFG Intime India

The share allotment status for the Corona Remedies IPO will be finalised today.

Events

4 w. ago IPO GMP: Corona Remedies Vs WakeFit – Latest Trends Suggest Over 25% Listing Pop For Investors

Shares of WakeFit Innovations and Corona Remedies are expected to list on the BSE and NSE on December 15.

Economics

4 w. ago Corona Remedies IPO GMP: What Does Grey Market Trends Suggest On Final Day Of Subscription

The grey market premium for the Corona Remedies IPO has increased on the final day of subscription.

Economics

4 w. ago IPO GMP: Corona Remedies Vs WakeFit – Latest Trends Suggest 25% Listing Pop For Investors

Shares of WakeFit Innovations and Corona Remedies are expected to list on the BSE and NSE on December 15.

Economics

4 w. ago Corona Remedies IPO: Subscribed Over Nine Times Day Two, GMP Advances

Corona Remedies Ltd. initial public offer was subscribed 9.33 times at the end of the second day on Tuesday.

Events

last month Corona Remedies IPO Day Two: Check Subscription Status, GMP, And Financials

Corona Remedies IPO was subscribed 5.28 times as of 2:37 p.m. on Tuesday.

Economics

last month IPO GMP: Wakefit vs Corona Remedies – Grey Market Trends On Day 2 Of Subscription

The current grey market trends suggests that the unlisted shares of Wakefit and Corona Remedies were trading at a premium of 2-25%.

Economics